'Why only cancer drugs?': SC questions Centre on trade margin cap, seeks wider price regulation

A bench of Justices Vikram Nath and Sandeep Mehta took note of the Centre's decision to impose a 30 per cent cap on trade margins for specified cancer drugs but sought to know why similar scrutiny could not extend to other medicines.
Read the full story on Mint Opens livemint.com in a new tab
This is a short summary of a story published by Mint, shown with a link to the original. The full story, photo and reporting belong to Mint.










